Evaluation of Histidine–Octamer-Modified Hyaluronic Acid as a Cytosolic Drug Delivery Material via CD44-Mediated Cellular Uptake and Endosomal Escape

Tomona Yukimura, Hirono Ito, Takahiro Suzuki, Toshinobu Seki, Tomohiro Seki

Open source

DOI
10.3390/pharmaceutics18091137
Published
2026-09-10
Container
Pharmaceutics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18091137,
  title = {Evaluation of Histidine–Octamer-Modified Hyaluronic Acid as a Cytosolic Drug Delivery Material via CD44-Mediated Cellular Uptake and Endosomal Escape},
  author = {Tomona Yukimura and Hirono Ito and Takahiro Suzuki and Toshinobu Seki and Tomohiro Seki},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18091137},
  url = {https://doi.org/10.3390/pharmaceutics18091137}
}

RIS

TY  - JOUR
TI  - Evaluation of Histidine–Octamer-Modified Hyaluronic Acid as a Cytosolic Drug Delivery Material via CD44-Mediated Cellular Uptake and Endosomal Escape
AU  - Tomona Yukimura
AU  - Hirono Ito
AU  - Takahiro Suzuki
AU  - Toshinobu Seki
AU  - Tomohiro Seki
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18091137
UR  - https://doi.org/10.3390/pharmaceutics18091137
ER  - 

APA

Yukimura, T., Ito, H., Suzuki, T., Seki, T., & Seki, T. (2026). Evaluation of Histidine–Octamer-Modified Hyaluronic Acid as a Cytosolic Drug Delivery Material via CD44-Mediated Cellular Uptake and Endosomal Escape. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18091137

Source records